Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension

Gastroenterology
A AlbillosJ Bosch

Abstract

The association of prazosin to propranolol enhances the decrease in portal pressure but may cause hypotension and sodium retention. The aim of this study was to compare the portal pressure reduction and safety of the combination of propranolol plus prazosin with that of propranolol plus isosorbide-5-mononitrate (ISMN). Fifty-six portal-hypertensive cirrhotics received randomly propranolol plus prazosin (n = 28) or propranolol plus ISMN (n = 28) orally for 3 months. Hemodynamics and liver and renal function were assessed at baseline and after 3 months. Propranolol plus prazosin caused a greater reduction in hepatic venous pressure gradient (HVPG) than propranolol plus ISMN (-24.2% +/- 11% vs. -16.1% +/- 11%; P < 0.01). A reduction in HVPG of > 20% was significantly more frequent in the propranolol plus prazosin group than in the propranolol plus ISMN group (85% vs. 53%; P < 0.05). Neither treatment modified hepatic blood flow, quantitative liver function test results, glomerular filtration rate, plasma renin activity, or plasma aldosterone level. Side effects occurred in 13 patients receiving propranolol plus prazosin compared with 7 receiving propranolol plus ISMN (P = 0.16). Propranolol plus prazosin has a greater portal press...Continue Reading

References

Jan 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G Garcia-TsaoJ L Alberts

❮ Previous
Next ❯

Citations

Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D S Zimmon, F Manheimer
Jun 3, 2006·Journal of Gastroenterology·Han-Chieh LinShou-Dong Lee
Mar 23, 2000·Journal of Hepatology·J Bosch, J C García-Pagán
Feb 20, 2003·Journal of Hepatology·Jaime BoschRoberto Groszmann
Aug 26, 1999·Ultrasound in Medicine & Biology·F PiscagliaL Bolondi
Sep 3, 2009·Nature Reviews. Gastroenterology & Hepatology·Jaime BoschJuan Carlos García-Pagan
Feb 24, 2001·Alimentary Pharmacology & Therapeutics·D Tripathi, P C Hayes
Dec 11, 2002·Journal of Gastroenterology and Hepatology·Juan G Abraldes, Jaime Bosch
Apr 23, 2002·Journal of Gastroenterology and Hepatology·Binay K DeAjit K Maity
Aug 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J Bosch
Nov 1, 2008·Drugs·Cándid Villanueva, Joaquim Balanzó
Mar 5, 2011·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Hamdan Al-Ghamdi
Nov 26, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rafael BañaresJaime Bosch
Dec 6, 2007·Journal of Clinical Gastroenterology·Agustín Albillos
Oct 19, 2010·Gastroenterology Clinics of North America·Cecilia Miñano, Guadalupe Garcia-Tsao
Mar 19, 2008·Best Practice & Research. Clinical Gastroenterology·A Dell'EraF Iannuzzi
Jun 6, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Puneeta TandonMang M Ma
Jan 27, 2004·Pharmacotherapy·Brian A Hemstreet
May 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Carlo Merkel
May 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Juan Carlos García-PagánUNKNOWN Spanish Variceal Bleeding Study Group
Aug 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jaime Bosch, Guadalupe Garcia-Tsao
Jul 3, 1998·Gastroenterology·L Blendis, F Wong
Oct 7, 2005·Clinics in Liver Disease·Juan G AbraldesJaime Bosch
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Juan G AbraldesJaime Bosch
Dec 14, 2005·Liver International : Official Journal of the International Association for the Study of the Liver·Wim LalemanFrederik Nevens
Jun 1, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jaime Bosch
Jan 29, 2011·Expert Opinion on Pharmacotherapy·Ulrich ThalheimerAndrew K Burroughs
Jul 5, 2015·Gastrointestinal Endoscopy Clinics of North America·Abdul Q Bhutta, Guadalupe Garcia-Tsao
May 6, 2016·Expert Opinion on Emerging Drugs·Harikumar NairJaime Bosch
Jul 1, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R BañaresJ Bosch
Jan 19, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Càndid VillanuevaCarlos Guarner
Jul 5, 2007·The American Journal of Gastroenterology·Julio D VorobioffHugo E Tanno
May 24, 2017·Gastroenterology Report·Philipp Schwabl, Wim Laleman
Apr 24, 2001·The American Journal of Gastroenterology·W C LeeS D Lee
Jul 6, 2004·The American Journal of Gastroenterology·Laura E TargownikIan M Gralnek
Nov 14, 2018·European Journal of Gastroenterology & Hepatology·Feng ZhangYuzheng Zhuge
May 28, 2005·Digestive Diseases·Jaime Bosch, Juan G Abraldes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.